Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products primarily in the United States, Europe, and South Korea. It offers Contrave for the treatment of obesity. The company also offers Contrave under the Mysimba brand name. Orexigen Therapeutics, Inc. was founded in 2002 and is headquartered in La Jolla, California. On March 12, 2018, Orexigen Therapeutics, Inc., filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Phone858-875-8600
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$33.71 million
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Orexigen Therapeutics (OTCMKTS:OREXQ) Frequently Asked Questions
What is Orexigen Therapeutics' stock symbol?
Orexigen Therapeutics trades on the OTCMKTS under the ticker symbol "OREXQ."
Has Orexigen Therapeutics been receiving favorable news coverage?
News articles about OREXQ stock have been trending somewhat negative on Friday, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Orexigen Therapeutics earned a media sentiment score of -1.5 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Orexigen Therapeutics.
Who are some of Orexigen Therapeutics' key competitors?
Some companies that are related to Orexigen Therapeutics include Propanc Biopharma (PPCB), Targeted Medical Pharma (TRGM), Spotlight Innovation (STLT), Skinvisible (SKVI), Inspyr Therapeutics (NSPX), Aeolus Pharmaceuticals (AOLS), Affymax (AFFY), American Oriental Bioengineering (AOBI), Aoxing Pharmaceutical (AOXG), Bohai Pharmaceuticals Group (BOPH), Eleven Biotherapeutics (EBIO), Epirus Biopharmaceuticals (EPRSQ), ERBA Diagnostics (ERBA), FutureWorld (FWDG) and GlobeImmune (GBIM).
Who are Orexigen Therapeutics' key executives?
Orexigen Therapeutics' management team includes the folowing people:
- Mr. Thomas P. Lynch, Consultant (Age 52)
How do I buy shares of Orexigen Therapeutics?
Shares of OREXQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Orexigen Therapeutics' stock price today?
One share of OREXQ stock can currently be purchased for approximately $0.01.
How big of a company is Orexigen Therapeutics?
What is Orexigen Therapeutics' official website?
How can I contact Orexigen Therapeutics?
Orexigen Therapeutics' mailing address is 3344 N. TORREY PINES CT. SUITE 200, LA JOLLA CA, 92037. The company can be reached via phone at 858-875-8600 or via email at [email protected]
MarketBeat Community Rating for Orexigen Therapeutics (OTCMKTS OREXQ)
MarketBeat's community ratings are surveys of what our community members think about Orexigen Therapeutics and other stocks. Vote "Outperform" if you believe OREXQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OREXQ will underperform the S&P 500 over the long term. You may vote once every thirty days.
